-+ 0.00%
-+ 0.00%
-+ 0.00%

CollPlant Biotechnologies FY 2024 Adj. EPS $(1.30) Beats $(1.44) Estimate, Sales $515.000K Miss $1.640M Estimate

Benzinga·03/26/2025 12:12:02
Listen to the news
CollPlant Biotechnologies (NASDAQ:CLGN) reported quarterly losses of $(1.30) per share which beat the analyst consensus estimate of $(1.44) by 9.72 percent. This is a 182.61 percent decrease over losses of $(0.46) per share from the same period last year. The company reported quarterly sales of $515.000 thousand which missed the analyst consensus estimate of $1.640 million by 68.60 percent.